Preclinical data with BBT002 demonstrate its best-in-disease potential for improved efficacy and dosing convenience across respiratory, derm...

PRIVATELY held Stealth BioTherapeutics said on Thursday the U.S. Food and Drug Administration had declined to approve its therapy for an ult...

URGN Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, May 29, 2025 /PRNewswire/ -- On May 21, 2025, investors in Uro...

The Centers for Disease Control and Prevention has estimated that salmonella causes about 420 deaths annually in the U.S.

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults might delay manufac...

The U.S. health agency's promises of transparency and choice for COVID-19 vaccines fall short in its first big test. 

SUZHOU, China, May 25, 2025 /PRNewswire/ -- In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that X...

Diners are advised against eating frozen, raw or half-shell oysters imported from the Republic of Korea

On day 2 of an FDA advisory meeting to consider a new treatment for non–muscle invasive bladder cancer, an FDA official warns of the implica...

The FDA is issuing a new warning about a rare but "severe" risk associated with the long-term use of certain over-the-counter allergy medica...

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("Dua...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall, but FDA offic...

(NEXSTAR) – Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the U.S...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 ye...

The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after v...